ArticleInternational journal of nanomedicine2022

Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma.

Yezi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.